CN Patent

CN110935024B — 长效组合物

Assigned to Hefei Cosource Pharmaceutical Co ltd · Expires 2023-08-08 · 3y expired

What this patent protects

本发明提供长效组合物，包括：酰胺类局麻药的难溶性复合物或其溶剂合物和非甾体抗炎药。该长效组合物可延长镇痛时间，还可发挥两者的协同效应。

USPTO Abstract

本发明提供长效组合物，包括：酰胺类局麻药的难溶性复合物或其溶剂合物和非甾体抗炎药。该长效组合物可延长镇痛时间，还可发挥两者的协同效应。

Drugs covered by this patent

Bupivacaine Hydrochloride And Epinephrine (BUPIVACAINE) · Innocoll

Patent Metadata

Patent number: CN110935024B
Jurisdiction: CN
Classification: —
Expires: 2023-08-08
Drug substance claim: No
Drug product claim: No
Assignee: Hefei Cosource Pharmaceutical Co ltd
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.